2020 McDonald Fellowships and Du Pré Grant recipients announced

23rd November 2020

MSIF is proud to announce the recipients of the 2020 McDonald Fellowships and Du Pré Grants, from…

What’s your MS research priority?

9th November 2020

A unique opportunity for people with MS and their families to share their MS research shortlists.

Time to connect – MS Canada invites you to their upcoming MS research conference

9th November 2020

Register for the MS Connect conference for the latest MS research updates

Esclerosis Múltiple Uruguay making paths out of obstacles

9th November 2020

Esclerosis Múltiple Uruguay (EMUR) share their recent work and reflect on the positives at this time of…

MS Australia puts Women’s Health in the spotlight

9th November 2020

MS Australia celebrates national Women's Health Week

How do we accelerate life-changing treatments for people with progressive MS?

9th November 2020

Join the discussion about research breakthroughs that could accelerate new treatments for people with progressive MS

Challenging false myths and prejudices for teenagers with MS

5th November 2020

A powerful series of animated graphics based on the experiences of teenagers with MS in Italy.

Responding to the data: new global COVID-19 advice for people with MS

23rd October 2020

Updated global advice for people with MS and the data behind it

The National MS Society holds first Black MS Experience Summit

21st October 2020

Being Black and living with MS brings unique challenges. The Black MS Experience Summit created a safe…

Adapting your lifestyle – a guide for people with MS

15th October 2020

MS Research Australia has released a lifestyle guide packed with practical and evidence-based recommendations for living well…

The campaign for rituximab in Iraq

15th October 2020

Al-Hayat Association in Iraq has successfully lobbied the Ministry of Health to provide better access to the…

A potential biomarker for progressive MS

15th October 2020

The use of neurofilament light chain (NfL) as a biomarker could revolutionise clinical trials in progressive MS.